Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Personalis, Inc. - Common Stock (NQ:PSNL)

8.480 +0.260 (+3.16%)
Streaming Delayed Price Updated: 12:29 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Personalis to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
From Personalis, Inc.
Via Business Wire
Personalis: Q2 Earnings Insights
Personalis (NASDAQ:PSNL) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Personalis beat estimated... 
Via Benzinga
Personalis Reports Second Quarter 2022 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis Files Patent Infringement Lawsuit Against Foresight Diagnostics
From Personalis, Inc.
Via Business Wire
Expert Ratings for Personalis
Personalis (NASDAQ:PSNL) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Personalis: Q4 Earnings Insights
Personalis (NASDAQ:PSNL) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Personalis to Announce Second Quarter 2022 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis Announces Expansion of Its Patent Portfolio Related to Tumor-Informed Detection of Molecular Residual Disease
From Personalis, Inc.
Via Business Wire
Personalis Reports First Quarter 2022 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis to Present at Upcoming Investor Conferences
From Personalis, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
During the Thursday's session, 100 stocks hit new 52-week lows. 
Via Benzinga
Evaxion to Utilize Personalis’ ImmunoID NeXT Platform® to Evaluate Efficacy of Combination Therapy for Late-Stage Melanoma
From Personalis
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 73 stocks hit new 52-week lows. 
Via Benzinga
Personalis Expands Diagnostic Leadership Team With Appointment of James Azzaro, Vice President of Diagnostic Sales
From Personalis, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
During Thursday, 351 stocks hit new 52-week lows. 
Via Benzinga
Personalis to Announce First Quarter 2022 Financial Results
From Personalis, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 236 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was... 
Via Benzinga
Personalis Publishes New Data Demonstrating Highly Sensitive Algorithm for Detecting Loss of Heterozygosity in HLA Gene
From Personalis, Inc.
Via Business Wire
Personalis Announces Issuance of Additional US Patent Related to the NeXT Personal™ Platform
From Personalis, Inc.
Via Business Wire
Personalis and Merck KGaA, Darmstadt, Germany to Present Comprehensive Tumor Subtyping Collaboration Data at AACR Annual Meeting 2022
From Personalis, Inc.
Via Business Wire
Personalis to Present at the 21st Annual Needham Virtual Healthcare Conference
From Personalis, Inc.
Via Business Wire
Diagnostic Industry Veteran Karin Eastham to Chair Personalis Board of Directors
From Personalis, Inc.
Via Business Wire
Personalis to Present Data Demonstrating Breadth of NeXT Platform for Oncology at AACR Annual Meeting 2022
From Personalis, Inc.
Via Business Wire
Personalis Reports Fourth Quarter and Full Year 2021 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis to Present at the Cowen 42nd Annual Health Care Conference
From Personalis, Inc.
Via Business Wire
Personalis Announces Collaboration with UC San Diego Moores Cancer Center for Clinical Genomic Testing and Research into Composite Biomarkers and Minimal Residual Disease Detection
From Personalis, Inc.
Via Business Wire
Personalis to Announce Fourth Quarter and Full-Year Financial Results
From Personalis, Inc.
Via Business Wire
Personalis to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Personalis, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning trading, 400 companies set new 52-week lows. 52-Week Low Highlights: Intuitive Surgical (NASDAQ:ISRG) was the largest company by... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.